Prolintane

Prolintane
Clinical data
Routes of; administration	oral, intranasal, rectal
ATC code	N06BX14 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); BR: Class B1 (Psychoactive drugs);
Identifiers
	IUPAC name 1-(1-phenylpentan-2-yl)pyrrolidine;
CAS Number	493-92-5 ;
PubChem CID	14592;
ChemSpider	13930 ;
UNII	EM4YZW677H;
ChEMBL	ChEMBL2111047 ;
ECHA InfoCard	100.007.077
Chemical and physical data
Formula	C15H23N
Molar mass	217.356 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	133 °C (271 °F)
Boiling point	153 °C (307 °F)
	SMILES CCCC(N1CCCC1)CC2=CC=CC=C2;
	InChI InChI=1S/C15H23N/c1-2-8-15(16-11-6-7-12-16)13-14-9-4-3-5-10-14/h3-5,9-10,15H,2,6-8,11-13H2,1H3 ; Key:OJCPSBCUMRIPFL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant and norepinephrine-dopamine reuptake inhibitor developed in the 1950s. Being an amphetamine derivative, it is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action. Many cases of prolintane abuse have been reported.

Under the trade-name "Katovit", prolintane was commercialized by the Spanish pharmaceutical company, FHER. Katovit was sold until 2001, and was most often used by students and workers as a stimulant to provide energy, promote alertness and concentration.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.